Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

ClinicalTrials.gov ID: NCT00046332

Public ClinicalTrials.gov record NCT00046332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Placebo-controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Doses of S-1360 Versus Placebo Over 10 Days in ART-naive HIV-1 Infected Adults.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.

Study identification

NCT ID
NCT00046332
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
100 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Dec 31, 2002
Completion
Dec 31, 2002
Last update posted
Feb 20, 2013

2002 – 2003

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
21
Facility City State ZIP Site status
GSK Clinical Trials Call Center Phoenix Arizona 85006
GSK Clinical Trials Call Center Los Angeles California 90048
GSK Clinical Trials Call Center San Diego California 92103
GSK Clinical Trials Call Center San Francisco California 94115
GSK Clinical Trials Call Center West Hollywood California 90069
GSK Clinical Trials Call Center Denver Colorado 80220
GSK Clinical Trials Call Center Washington D.C. District of Columbia 20007
GSK Clinical Trials Call Center Altamonte Springs Florida 32701
GSK Clinical Trials Call Center Fort Lauderdale Florida 33311
GSK Clinical Trials Call Center Miami Florida 33133
GSK Clinical Trials Call Center Tampa Florida 33614
GSK Clinical Trials Call Center Atlanta Georgia 30308
GSK Clinical Trials Call Center Indianapolis Indiana 46202
GSK Clinical Trials Call Center Minneapolis Minnesota 55404
GSK Clinical Trials Call Center New York New York 10008
GSK Clinical Trials Call Center New York New York 10011
GSK Clinical Trials Call Center New York New York 10032
GSK Clinical Trials Call Center The Bronx New York 10461
GSK Clinical Trials Call Center Chapel Hill North Carolina 27599
GSK Clinical Trials Call Center Charlotte North Carolina 28203
GSK Clinical Trials Call Center Durham North Carolina 27710
GSK Clinical Trials Call Center Dallas Texas 75235
GSK Clinical Trials Call Center Houston Texas 77004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2013 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00046332 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →